Equities

Nanologica AB (publ)

Nanologica AB (publ)

Actions
Basic MaterialsChemicals
  • Price (SEK)1.95
  • Today's Change0.045 / 2.37%
  • Shares traded208.05k
  • 1 Year change-80.71%
  • Beta0.5612
Data delayed at least 15 minutes, as of Nov 12 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.

  • Revenue in SEK (TTM)7.63m
  • Net income in SEK-76.29m
  • Incorporated2004
  • Employees16.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
aXichem AB (publ)7.24m-17.19m58.44m7.00--0.9044--8.08-0.757-0.7570.27281.600.0930.89320.85651,033,857.00-22.10-26.89-27.83-30.93-9.67-208.30-237.57-621.552.26-5.610.0714---63.8739.37-20.59--6.79--
Horisont Energi AS5.28m-121.63m64.51m35.00--0.5166--12.21-5.54-5.540.24095.690.0229--4.87141,510.50-52.62---64.84-------2,301.45------0.0448-------44.23------
Prebona AB6.64m-7.62m64.86m----29.78--9.77-0.2815-0.28150.24510.07450.3873-0.0213.84---44.46-50.22-59.06-83.03100.41122.67-114.79-151.150.9022-3.960.7783--158.1836.1024.69--24.45--
Circa Group AS13.67m-84.76m76.30m17.00--0.2335--5.58-0.8071-0.80710.12872.720.02875.120.6574818,117.90-17.78---24.28--69.51---620.10--0.3975--0.00--41.73---0.0491------
Triboron International AB118.20m-11.60m77.52m17.00--3.16--0.6559-0.1236-0.12361.290.15651.764.648.816,952,706.00-17.26-63.80-39.61-98.8819.6120.45-9.82-99.540.4575-3.680.5943--12,111.31132.32-20.14---29.27--
CirChem AB8.22m-11.72m80.72m13.00--2.38--9.82-0.4079-0.40790.28561.090.142947.219.72822,152.00-20.38-28.94-28.28-40.4312.43-569.62-142.61-1,086.470.8756-10.570.1734--872.63102.7324.55---40.02--
Svenska Aerogel Holding AB (publ)2.37m-38.34m88.83m16.00--1.77--37.48-0.0683-0.06830.00360.05290.0303-0.08064.73148,125.00-48.97-50.34-70.13-67.01107.6878.18-1,617.68-1,586.971.84-16.510.0703---50.9868.11-9.53---41.29--
Pryme NV704.21k-284.68m155.16m41.00--0.3611--220.34-7.50-7.500.01657.150.00124.310.046217,476.69-39.48---42.17---5,432.79---40,424.59--2.00-43.520.2239-------239.24------
Nanologica AB (publ)7.63m-76.29m156.94m16.00--5.99--20.57-1.97-1.970.19190.3170.06620.34754.72476,750.00-66.17-42.66-80.34-49.5845.0374.47-1,000.11-529.381.61-11.090.0793---7.20-19.03-36.08--47.76--
Bergen Carbon Solutions AS-88.45k-60.20m164.79m32.00--0.8557-----1.46-1.46-0.00214.67-0.00043.47---3,750.00-24.78-23.06-25.94-24.17---195.75---15,628.1518.63--0.0714---100.00---19.55------
RIAS A/S475.75m15.23m191.49m105.0014.540.79686.810.402542.6442.641,331.76778.091.316.215.91--4.194.845.096.1032.7632.283.203.762.0432.180.044259.19-7.552.63-26.2513.383.558.16
OrganoClick AB133.71m-17.56m282.58m41.00--7.671,605.572.11-0.1791-0.17911.360.37570.86682.875.083,183,524.00-10.05-15.65-28.07-29.1320.6017.72-11.60-22.550.3432-2.270.5070--26.7913.2264.48--13.42--
Nexam Chemical Holding AB202.22m-8.95m343.08m53.00--1.8462.331.70-0.1106-0.11062.502.310.81052.736.563,744,833.00-3.59-5.14-4.20-5.9845.7640.82-4.43-7.101.34-5.350.105---14.2211.27-79.78--10.64--
Data as of Nov 12 2024. Currency figures normalised to Nanologica AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

3.32%Per cent of shares held by top holders
HolderShares% Held
Swedbank Robur Fonder ABas of 30 Sep 20242.52m2.85%
Handelsbanken Fonder ABas of 30 Sep 2024258.73k0.29%
FCG Fonder ABas of 30 Sep 2024158.98k0.18%
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.